scispace - formally typeset
R

Roberto Gotti

Researcher at University of Bologna

Publications -  146
Citations -  4777

Roberto Gotti is an academic researcher from University of Bologna. The author has contributed to research in topics: Capillary electrophoresis & Micellar electrokinetic chromatography. The author has an hindex of 31, co-authored 136 publications receiving 4095 citations.

Papers
More filters
Journal ArticleDOI

Gut microbiome of the Hadza hunter-gatherers

TL;DR: It is shown that the Hadza have higher levels of microbial richness and biodiversity than Italian urban controls, and enrichment in Prevotella, Treponema and unclassified Bacteroidetes, as well as a peculiar arrangement of Clostridiales taxa, may enhance the hadza’s ability to digest and extract valuable nutrition from fibrous plant foods.
Journal ArticleDOI

Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC)

TL;DR: Reverse phase HPLC procedures (ODS column) were developed able to provide a single, symmetric peak for each drug and mixtures A-B, where A is 20 mM sodium heptansulphonate and B is acetonitrile-THF, proved to be suitable mobile phases to obtain selective separations of the cited ACE inhibitors.
Journal ArticleDOI

Oxalate consumption by lactobacilli : evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus

TL;DR: Evaluated the oxalate‐degrading activity in several Lactobacillus species widely used in probiotic dairy and pharmaceutical preparations to assess the possible contribution of LactOBacillus in regulating the intestinal oxalates homeostasis.
Journal ArticleDOI

Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT.

TL;DR: The first longitudinal study to follow the gut microbiota trajectory, from both the phylogenetic and functional points of view, in pediatric patients undergoing HSCT, indicates that structure and temporal dynamics of the gut microbial ecosystem can be a relevant factor for the success of HSCT and opens the perspective to the manipulation of the pre-HSCT gut microbiota configuration to favor mutualistic persisters with immunomodulatory properties in the gut.